Shortages to backbone chemotherapy drugs are negatively affecting patient care, and more shortages are likely without policy solutions, experts say.

Drug shortages have decreased but remain significant, with 50% persisting over two years, affecting critical medications. Shortages stem from product-specific issues, market constraints, and access ...

Researchers at Northwestern University published in ACS Nano have redesigned a common chemotherapy drug using nanotechnology, ...

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...

Vital chemotherapy drugs used around the world have failed quality tests, putting cancer patients in more than 100 countries at risk of ineffective treatments and potentially fatal side effects, an ...